WCN25-2327 EMPOWERED WHARTON JELLY-DERIVED MESENCHYMAL STROMAL CELLS AS A THERAPEUTIC OPTION FOR ACUTE KIDNEY INJURY
Saved in:
| Main Authors: | Diksha Makkar, Diksha Gakhar, Aruna Rakha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924028493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton’s Jelly Mesenchymal Stromal Cells
by: Raquel Cabrera-Pérez, et al.
Published: (2025-06-01) -
Wharton’s jelly mesenchymal stromal cells derived from preterm umbilical cord reveal a hepatogenic potential
by: F. Timoneri, et al.
Published: (2025-06-01) -
Enhancing adipogenesis in Wharton’s jelly multipotent mesenchymal stromal cells through lipidomic insights and fatty acid supplementation
by: Olena Rogulska, et al.
Published: (2025-08-01) -
Xenotransplantation of Human Umbilical Mesenchymal Stromal Cells Derived from Wharton's Jelly Mitigates Mouse Amyotrophic Lateral Sclerosis
by: Chun-Fu Lin, et al.
Published: (2025-07-01) -
COMPARISON OF THE IMMUNOMODULATORY PROPERTIES OF THE CORD BLOOD AND WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS
by: Ayşe Erol, et al.
Published: (2023-06-01)